Page 2,457«..1020..2,4562,4572,4582,459..2,4702,480..»

The Powers of Dental Pulp Derived Stem Cells DPSC Overview and Technology – Video

Posted: January 14, 2013 at 6:42 am


The Powers of Dental Pulp Derived Stem Cells DPSC Overview and Technology
Dental pulp derived stem cells can be used to repair teeth, by facilitating the growth of dentin or pul pulp in a compromised tooth. thaimedicalvacation.com It also allows for the creation of biological scaffolding from wisdom teeth. The re-growth of dental pulp and dentin was don to apply the successful methods to repair damage caused by dental trauma. Dental Pulp stem cells have the ability to differentiate into various other types of tissue such as bone, neural cells and as a source for iPS derived cells, Dental stem cells Can also be a potential source of stem cells that can be utilized to treat a wide variety of disease and trauma as regenerative medical treatments.

By: stemcellthailand

Read more:
The Powers of Dental Pulp Derived Stem Cells DPSC Overview and Technology - Video

Posted in Stem Cell Videos | Comments Off on The Powers of Dental Pulp Derived Stem Cells DPSC Overview and Technology – Video

Beating Cardiomyocytes from human embryonic stem cells.avi – Video

Posted: January 14, 2013 at 6:42 am


Beating Cardiomyocytes from human embryonic stem cells.avi
Human embryonic stem cells were differentiated into beating cardiomyocytes via embryoid body mediated differentiation. STEM CELL LIFE SCIENCE CONSULTING

By: SCLSConsulting

Original post:
Beating Cardiomyocytes from human embryonic stem cells.avi - Video

Posted in Stem Cell Videos | Comments Off on Beating Cardiomyocytes from human embryonic stem cells.avi – Video

SammyJo Wilkinsin talks at the Houston Stem Cell Summit – Video

Posted: January 14, 2013 at 6:42 am


SammyJo Wilkinsin talks at the Houston Stem Cell Summit
I was on a panel of 4 patients, all treated with our own adult stem cells. Each of us had great restorative effects for serious ailments like multiple sclerosis, arthritis, or orthopedic conditions. Now the FDA made an overzealous ruling our own stem cells are a drug, if expanded to reach a therapeutic dose. Now this therapy is no longer available in the US as of the start of 2013. So be cautious when evaluating clinics that offer a low-dose therapy for a serious condition like MS. For comparison, I received 600 million of my own adipose-derived autologous mesenchymal stem cells. The FDA is forcing patients into medical tourism to achieve effective therapy. But stay tuned, PatientsForStemCells.com is a group of patients who are fighting for every sick person #39;s right to use their own stem cells for repair, restoration and recovery from grave illnesses, many of which have no other effective treatment. SammyJo Wilkisnon

By: SammyJo Wilkinson

See more here:
SammyJo Wilkinsin talks at the Houston Stem Cell Summit - Video

Posted in Stem Cell Videos | Comments Off on SammyJo Wilkinsin talks at the Houston Stem Cell Summit – Video

Drug enables deafened mice to hear again – Video

Posted: January 14, 2013 at 6:42 am


Drug enables deafened mice to hear again
Drug Enables Deafened Mice to Hear Again news.sciencemag.org Ref.: Notch Inhibition Induces Cochlear Hair Cell Regeneration and Recovery of Hearing after Acoustic Trauma Hellfireeuron, Volume 77, Issue 1, 58-69, 9 January 2013, DOI: 10.1016/j.neuron.2012.10.032 http://www.cell.com Highlights bull;Sensory hair cell regeneration is demonstrated in an adult mammal bull;Inhibition of Notch stimulates hair cell regeneration after acoustic trauma bull;Hair cells are derived from transdifferentiation of cochlear supporting cells bull;Frequency region of hearing recovery corresponds to area of hair cell replacement Summary Hearing loss due to damage to auditory hair cells is normally irreversible because mammalian hair cells do not regenerate. Here, we show that new hair cells can be induced and can cause partial recovery of hearing in ears damaged by noise trauma, when Notch signaling is inhibited by a -secretase inhibitor selected for potency in stimulating hair cell differentiation from inner ear stem cells in vitro. Hair cell generation resulted from an increase in the level of bHLH transcription factor Atoh1 in response to inhibition of Notch signaling. In vivo prospective labeling of Sox2-expressing cells with a Cre-lox system unambiguously demonstrated that hair cell generation resulted from transdifferentiation of supporting cells. Manipulating cell fate of cochlear sensory cells in vivo by pharmacological inhibition of Notch signaling is thus a potential therapeutic approach to the treatment ...

By: Stefano Di Criscio

Original post:
Drug enables deafened mice to hear again - Video

Posted in Stem Cell Videos | Comments Off on Drug enables deafened mice to hear again – Video

Why are stem cells important .mp4 – Video

Posted: January 14, 2013 at 6:42 am


Why are stem cells important .mp4
http://www.stemcellsarthritistreatment.com Stem cells are important for for many reasons. In the 3- to 5-day-old embryo, cells give rise to the entire body of the organism, including all of the many specialized cell types and organs. In some adult tissues, such as bone marrow, muscle, and brain, discrete populations of adult stem cells generate replacements for cells that are lost through normal wear and tear, injury, or disease. Given their unique regenerative abilities, stem cells offer new potentials for treating diseases. http

By: Nathan Wei

Read this article:
Why are stem cells important .mp4 - Video

Posted in Stem Cell Videos | Comments Off on Why are stem cells important .mp4 – Video

Gene Therapies Will Cure Many a Disease (preview)

Posted: January 13, 2013 at 8:02 am

The Science Of The Next 150 Years: 50 Years in the Future [More]

Add to digg
Add to StumbleUpon
Add to Reddit
Add to Facebook
Add to del.icio.us
Email this Article


Source:
http://rss.sciam.com/click.phdo?i=72f945621480bfc5969f6a7a29254aaf

Posted in Gene therapy | Comments Off on Gene Therapies Will Cure Many a Disease (preview)

The Science of the Next 150 Years

Posted: January 13, 2013 at 8:02 am

What scientific and technological milestones can we envision 50, 100 and 150 years hence?

[More]

Add to digg
Add to StumbleUpon
Add to Reddit
Add to Facebook
Add to del.icio.us
Email this Article


Source:
http://rss.sciam.com/click.phdo?i=bb22bbe61dfa476fb230c7787f0d7954

Posted in Gene therapy | Comments Off on The Science of the Next 150 Years

Nature Biotechnology: California Stem Cell Agency Receives ‘Stinging Rebuke’

Posted: January 13, 2013 at 8:01 am

The headline this week in Nature
Biotechnology
read: “IOM smacks down California Institute of
Regenerative Medicine.”
The story by Senior Editor Laura
DeFrancesco
said that the $3 billion California stem cell agency
“received a stinging rebuke of much of the way it has been carrying
out its business by a group of independent reviewers.”
At the same time, DeFranesco wrote that
the blue-ribbon, Institute of Medicine panel “praised the courage
and vision of the individuals who spearheaded the program as well as
those toiling in the CIRM office in San Francisco.”
The Nature Biotechnology piece covered
familiar ground for many readers, summarizing the IOM's sweepingrecommendations last month, including those dealing with the built-in
conflicts of interest on the agency's 29-member governing board.
DeFrancesco wrote that is unclear
whether the agency will move to adopt any of the recommendations from
the panel, many of which have been rejected in the past.
Some members of the CIRM governing
board last month bristled at some of the recommendations. The board is scheduled to discuss the IOM report, for
which it paid $700,000, at a public meeting Jan. 23 in Berkeley.
Patient advocates are already organizing a turn-out to lobby against
some recommendations.  

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/bJIhSwMvwx8/nature-biotechnology-california-stem.html

Posted in Stem Cells, Stem Cell Therapy | Comments Off on Nature Biotechnology: California Stem Cell Agency Receives ‘Stinging Rebuke’

Roman Reed is Stem Cell Person of 2012; Leigh Turner Runner-up

Posted: January 13, 2013 at 8:01 am

Roman Reed, a Fremont, Ca., patient advocate, this week was named Stem
Cell Person of 2012
by the Knoepfler Stem Cell Lab at UC Davis, which
cited Reed for energizing a new generation of
advocacy.

Roman Reed (left) and Paul Knoepfler
Knoepfler Lab photo
UC Davis stem cell scientist Paul
Knoepfler
awarded Reed $1,000 from his personal funds. The ceremonial
check appears to be close to four-feet long in a photo taken in
Knoepfler's lab.
Knoepfler wrote on his blog that Reed
made a “tremendous difference” in 2012. The researcher said,

“One of the most notable was
catalyzing the TJ Atchison Spinal Cord Injury Research Act in
Alabama, which provides $400,000/year in funding for research. Of
course, TJ and many others who helped make this possible also deserve
great credit and have my admiration, but Roman provided key
leadership. Here in California, Roman’s Law supported its 11th
year of grants all eligible for all forms of stem cell research.
Roman informs me that it funded $749,00 overall and approximately
$200,000 in stem cell funding. 

“In addition, Roman in 2012 mentored
and energized a whole new generation of advocacy from young,
energetic leaders: TJ Atchison, Katie Sharify, Richard Lajara
and Tory Minus.”

Knoepfler personally made the decision on the award,
but also conducted an advisory poll that Reed won. Knoepfler wrote,

Leigh Turner
U of Minn photo

“Only 6% behind Roman was the amazing
activist Ted Harada followed by Roman’s dad the remarkable Don
Reed
, the wonderful Judy Roberson, and the super Katie Sharify nearly
all tied for third. Next after them was the relative new kid in stem
cell town, Leigh Turner.”

Knoepfler named Turner, an associate
professor at the Center for Bioethics at the University of Minnesota,
as the official runner-up in the contest, No. 2 behind Reed.
Knoepfler wrote,

“Leigh took the courageous,
outside-the-box step in 2012 of contacting the FDA to investigate
Celltex when he perceived patients could be at risk. As “thanks”
for his action, he was put under enormous pressure and there was talk
of possible litigation against him. Pressure was applied to his
employer, the University of Minnesota. We’ll never know for sure,
but from everything that I know I believe that Leigh’s actions
directly led to prompt FDA action, which otherwise might not have
happened at all or until much later. In my opinion, Leigh’s act of
courage, helped make hundreds of patients safer in a direct way and
indirectly may have set a higher standard for the field of stem cell
treatments.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/QfG7CijBsy4/roman-reed-is-stem-cell-person-of-2012.html

Posted in Stem Cells, Stem Cell Therapy | Comments Off on Roman Reed is Stem Cell Person of 2012; Leigh Turner Runner-up

BioTime Stock Jumps 22 Percent in Two Days in Wake of Geron Deal

Posted: January 13, 2013 at 8:01 am

The stock price of Biotime, Inc., of
Alameda, Ca., shot up more than 12 percent today following the
announcement of a complex deal that will give it the stem cell assets
of Geron Corp., the first firm to launch a clinical trial for an hESC
therapy.

Geron stock price Jan. 2-8
Google chart
BioTime stock closed at $3.88, up
43 cents or 12.46 percent. That followed a 9.6 percent gain
yesterday. Geron's stock closed at $1.63, up three cents or 1.9
percent.
News coverage of the deal was light
with our tracking showing only one story so far today on The Scientist magazine web site.

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/mQRu0qUrqwM/biotime-stock-jumps-22-percent-in-two.html

Posted in Stem Cells, Stem Cell Therapy | Comments Off on BioTime Stock Jumps 22 Percent in Two Days in Wake of Geron Deal

Page 2,457«..1020..2,4562,4572,4582,459..2,4702,480..»